Tylenol and Autism: FDA Warning Claims Fact-Checked

The American College of Obstetricians and Gynecologists said the announcement was "not backed by the full body of scientific evidence," with ACOG president Dr. Steven Fleischman noting that no reputable study in more than two decades has concluded acetaminophen causes neurodevelopmental disorders. ^[2]

The Autism Science Foundation said the claim "risks undermining public health while also misleading families who deserve clear, factual information," adding that autism "doesn't have a single cause" but is "the result of a complex mix of genetics and environmental factors." ^[3]

Kenvue, Tylenol's manufacturer, said in a statement: "We believe independent, sound science clearly shows that taking acetaminophen does not cause autism." ^[6]

The most rigorous study on the question is a 2024 JAMA analysis of 2.48 million Swedish children, led by Ahlqvist et al., which used a sibling-control design specifically to strip out genetic and household confounding. ^[4]

Without sibling controls, acetaminophen use showed a small statistical association with autism (hazard ratio 1.05). Once siblings were compared against each other, that association disappeared (hazard ratio 0.98; 95% CI, 0.93–1.04). ^[4]

The study's own authors concluded the earlier associations "may have been attributable to confounding" — meaning the reasons a mother takes acetaminophen (fevers, infections, chronic pain) may themselves be linked to neurodevelopmental outcomes, independent of the drug. ^[4]

Yale epidemiologist Dr. Zeyan Liew, who studies this question, summarized the state of the science plainly: "We do not know yet for sure whether acetaminophen causes autism." ^[5]

The claim that Tylenol causes autism outpaces the evidence behind it. The largest, most rigorously controlled study on the question — designed specifically to rule out confounding — found no causal link, and the FDA's own label-change proposal stopped short of asserting one. ACOG, the Autism Science Foundation, independent researchers, and Kenvue itself all say the question remains genuinely unresolved, not settled in the direction the September 2025 announcement implied. Pregnant women with questions about pain or fever management should talk to their own doctor rather than treat either side of this debate as closed.